This is a preview. Log in through your library . Abstract Combined vaccine formulations targeting not only hemagglutinin but also other influenza virus antigens could form the basis for a universal ...
Researchers found that the relative efficacy of the modRNA vaccine was 34.5% against influenza-like illness compared with the control vaccine, on the basis of 57 and 87 cases in the modRNA and control ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results